These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 19053980)

  • 1. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
    Silk DB; Davis A; Vulevic J; Tzortzis G; Gibson GR
    Aliment Pharmacol Ther; 2009 Mar; 29(5):508-18. PubMed ID: 19053980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
    Guyonnet D; Chassany O; Ducrotte P; Picard C; Mouret M; Mercier CH; Matuchansky C
    Aliment Pharmacol Ther; 2007 Aug; 26(3):475-86. PubMed ID: 17635382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC; Croffut RM; Stranahan MC
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
    Colecchia A; Vestito A; La Rocca A; Pasqui F; Nikiforaki A; Festi D;
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial.
    Bittner AC; Croffut RM; Stranahan MC; Yokelson TN
    Clin Ther; 2007 Jun; 29(6):1153-60. PubMed ID: 17692729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
    Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of pectin in the treatment of diarrhea predominant irritable bowel syndrome].
    Xu L; Yu W; Jiang J; Feng X; Li N
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):267-71. PubMed ID: 25809332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study.
    Andriulli A; Neri M; Loguercio C; Terreni N; Merla A; Cardarella MP; Federico A; Chilovi F; Milandri GL; De Bona M; Cavenati S; Gullini S; Abbiati R; Garbagna N; Cerutti R; Grossi E
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S218-23. PubMed ID: 18685503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
    Kajander K; Korpela R
    Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
    Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
    J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota.
    Mitsou EK; Turunen K; Anapliotis P; Zisi D; Spiliotis V; Kyriacou A
    Int J Food Microbiol; 2009 Oct; 135(2):112-7. PubMed ID: 19735957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ
    Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome.
    Tsuchiya J; Barreto R; Okura R; Kawakita S; Fesce E; Marotta F
    Chin J Dig Dis; 2004; 5(4):169-74. PubMed ID: 15612887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.